Schmitz Cargobull is a competent partner for pharmaceutical customers

June 2021 – Strict rules have been laid down by the EU for the transport of temperature-controlled pharmaceutical products with its GDP guidelines, which mandate a reliable quality management system across the entire supply chain. Schmitz Cargobull’s TrailerConnect® telematics system has now been re-certified by TÜV Süd following a comprehensive audit. The GDP certificate is valid for another two years. Transport companies that require GDP certification for the temperature-controlled transport of sensitive pharmaceutical products rely on Schmitz Cargobull as a competent and reliable partner. 

“After we were granted GDP certification by TÜV Süd for the first time in 2018, the feedback was very positive. Thanks to the certification of TrailerConnect, our customers were able to present an important certificate for their GDP audits, attesting the high quality and safety of our products,” reports Marnix Lannoije, Managing Director of Cargobull Telematics. “In addition, we were told by our customers that the GDP certificate is an essential element in obtaining authorisation for the transport of Covid-19 vaccines.”

The pharmaceuticals industry has been growing rapidly worldwide for many years. The transport volume and particularly the demand for end-to-end monitoring and documentation of the supply chain have been growing at the same time. As a result, in 2013 the European Commission introduced guidelines on Good Distribution Practice (GDP) of medicinal products for human use for quality assurance and protection against counterfeit medicines. Manufacturers, pharmaceutical wholesalers and pharmacists must subject their processes to yearly GDP audits. “With our GDP certificate we can document complete process reliability over the entire supply chain for our customers from the recording of data in the trailer and its storage through to its presentation in the portal or transmission in the API (interface for the transfer of data to third-party systems),” explains Marnix Lannoije.